Recently Viewed

Clear All
  • Home
  • Stories
  • News Announcement
  • Onesource Specialty Pharma: Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015
News Announcement

Onesource Specialty Pharma: Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015

09-Jul-2026 Follow Value Research Online on Google download pdfDownload PDF Onesource Specialty Pharma

We refer to the intimation made earlier today by Dr. Reddys Laboratories (DRL) regarding delay in commercial supplies of Semaglutide. Refer intimation attached.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan